Belgium

News

T. Ishiguchi & Dotarem (Drugs RD 2010)

19.11.2010 14:49

A study conducted on 3.444 patients during 4 year showed an excellent (99,53 %) global efficacy rate as well as a very good safety of Dotarem : <1 % adverse reactions and absence of serious ones during the survey period. See abstract.